From Generative Molecular Design to Agentic Artificial Intelligence in Drug Discovery
ChemMedChem · 12.11.2026 · 21 (21)
DOI: 10.1002/cmdc.70564 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 05.11.2026. Verfasst von Andrea Mastropietro und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science Informatics and Data Science, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilh…. Hauptthemen laut MEDLINE: Drug Discovery, Artificial Intelligence, Drug Design. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Over the past decade, artificial intelligence (AI) has increasingly influenced the early stages of drug discovery, which focus primarily on target evaluation and the design or identification of new active small molecules or biologics. Deep neural networks adapted from areas such as natural language processing and computer vision have provided novel opportunities for generative modeling and human–machine interactions. State‐of‐the‐art AI models for generative molecular design have emerged, but remain only little understood so far. Furthermore, new computational systems are being devised rapidly that are expected to significantly transform the drug discovery landscape in the near future. These developments pose challenges to computer‐aided drug discovery in various ways. In the following, we discuss these opportunities and challenges, with a focus on molecular design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Science Informatics and Data Science, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms Universität, Bonn, Germany.
- Lamarr Institute for Machine Learning and Artificial Intelligence, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
- Data Science Center, Nara Institute of Science and Technology, Ikoma, Nara, Japan.
ORCID-Profile: Andrea Mastropietro, Jürgen Bajorath
Zitieren
APA
Mastropietro, A., & Bajorath, J. (2026). From Generative Molecular Design to Agentic Artificial Intelligence in Drug Discovery. ChemMedChem, 21(21). https://doi.org/10.1002/cmdc.70564
Vancouver
Mastropietro A, Bajorath J. From Generative Molecular Design to Agentic Artificial Intelligence in Drug Discovery. ChemMedChem. 2026;21(21). doi:10.1002/cmdc.70564
BibTeX
@article{Mastropietro2026,
author = {Mastropietro, Andrea and Bajorath, Jürgen},
title = {From Generative Molecular Design to Agentic Artificial Intelligence in Drug Discovery},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {21},
doi = {10.1002/cmdc.70564}
}
EUVIMED